ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 11:35:24 2024-04-26 am EDT			5-day change	1st Jan Change
3.15 ^EUR	-2.63%		-17.21%	-52.99%

Mar. 25	Carmat: final agreement with creditors	CF
Mar. 25	Carmat Secures Two-year Extensions for Bank Loans	MT

Carmat SA announced that it has received ?16.5186 million in funding

January 28, 2024

On January 29, 2024, Carmat SA closed the transaction. The company has now issued 4,140,000 common shares at a price of ?3.99 per share for gross proceeds of ?16,518,600.

Latest news about CARMAT

Carmat: final agreement with creditors	Mar. 25	CF
Carmat Secures Two-year Extensions for Bank Loans	Mar. 25	MT
CARMAT Announces a Final Agreement with All Its Financial Creditors on New Repayment Terms for Its Bank Loans	Mar. 22	CI
Carmat: up sharply, broker upgrades to 'buy	Feb. 01	CF
CARMAT : Invest Securities upgrades to 'buy'.	Feb. 01	CF
Oddo BHF Keeps Carmat at Neutral, Cuts PT	Jan. 29	MT
France’s Carmat Secures EUR17 Million via Capital Raise; Shares Fall	Jan. 29	MT
CARMAT : price target lowered by Oddo BHF	Jan. 29	CF
Carmat: capital increase completed	Jan. 29	CF
Carmat SA announced that it has received ?16.5186 million in funding	Jan. 28	CI
CARMAT : Invest Securities advises to subscribe	Jan. 18	CF
Transcript : Carmat SA - Special Call	Jan. 17
Carmat: launches a capital increase	Jan. 17	CF
Carmat SA announced that it expects to receive ?15.000002 million in funding	Jan. 16	CI
Carmat: has passed the 50-implant milestone	Jan. 15	CF
Artificial heart maker Carmat to launch capital increase soon	Jan. 15	RE
Carmat Sa Provides Sales Guidance for the Year 2024	Jan. 15	CI
Carmat: conditional agreement in principle with the EIB	Jan. 12	CF
Carmat Secures In-principle Extension for European Investment Bank Loan	Jan. 12	MT
Carmat SA Announces Conditional Agreement in Principle with the EIB on New Loan Repayment Terms	Jan. 12	CI
CAC40: modest rise in non-existent volumes	Dec. 29	CF
CAC40: stalls below 7,570, W-Street crumbles, OAT tension	Dec. 29	CF
CAC40: attempts to cling to 7,570, sharp rise in OAT/Bund rates	Dec. 29	CF
CAC40: a slight rise, with the luxury sector providing support	Dec. 29	CF
Carmat Announces Software Enhancement for Artificial Heart	Dec. 29	MT

CARMAT specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all medication alternatives.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-15 - Gilbert Dupont Société Générale MidCap Forum

More about the company

Income Statement Evolution

More financial data

Ratings for CARMAT

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.15 EUR

Average target price

14.22 EUR

Spread / Average Target

+351.43%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
CARMAT	-52.99%	83.34M
STRYKER CORPORATION	+12.07%	128B
SMITH & NEPHEW PLC	-9.04%	10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.91%	8.82B
INSPIRE MEDICAL SYSTEMS, INC.	+16.72%	7.19B
GLAUKOS CORPORATION	+25.15%	4.99B
AXONICS, INC.	+7.17%	3.4B
ENOVIS CORPORATION	-1.36%	3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8.73%	2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10.15%	2B

Medical Devices & Implants

CARMAT

Equities

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Carmat SA announced that it has received ?16.5186 million in funding

Latest news about CARMAT

Chart CARMAT

Company Profile

Income Statement Evolution

Ratings for CARMAT

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Devices & Implants